Leif M. Laakso

402 citations
6 papers · 308 indexed · h-index 6
Topics
Bioactive Compounds and Antitumor Agents (2 papers)Protein Kinase Regulation and GTPase Signaling (2 papers)Signaling Pathways in Disease (2 papers)
Partner nations
United StatesCanada

In The Last Decade

Leif M. Laakso

6 papers receiving 301 citations

Peers

Leif M. Laakso
Comparison fields: 5 of 55
  • Organic Chemistry 163
  • Molecular Biology 133
  • Pharmacology 59
  • Oncology 55
  • Cancer Research 49
Replace Manus Ipek with:
Manus Ipek United States
Louise H. Foley United States
H. Robin Heyman United States
Weixin Xu United States
J. Schmid United States
John L. Gilmore United States
Elizabeth A. Malloy United States
Francis J. Sweeney United States
Fabien Lecomte United Kingdom
Timothy D. Cushing United States
Leif M. Laakso relative to Manus Ipek United States Manus Ipek's profile →
Citations per field
00.5×1.5×
Manus Ipek · 1×
Citations per year

Countries citing papers authored by Leif M. Laakso

Since Specialization
Citations

This map shows the geographic impact of Leif M. Laakso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif M. Laakso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif M. Laakso more than expected).

Fields of papers citing papers by Leif M. Laakso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif M. Laakso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif M. Laakso. The network helps show where Leif M. Laakso may publish in the future.

Co-authorship network of co-authors of Leif M. Laakso

This figure shows the co-authorship network connecting the top 25 collaborators of Leif M. Laakso. A scholar is included among the top collaborators of Leif M. Laakso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif M. Laakso. Leif M. Laakso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 64
2 37
3 90
4 45
5 22
6 50

About Leif M. Laakso

Leif M. Laakso is a scholar working on Toxicology, Immunology and Allergy and Pharmacology, having authored 6 papers that have together received 308 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Toxicology (30 citations), Organic Chemistry (163 citations) and Pharmacology (59 citations). Leif M. Laakso has collaborated with scholars based in United States and Canada. Frequent co-authors include Jeremy I. Levin, Karl J. Hale, Kwunmin Chen, Amos B. Smith, Antoni Riéra, Jerauld S. Skotnicki, J. Schmid, Jun Xu, Xuemei Du and Wei Li. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026